A Five-Year Study of Intrapleural Fibrinolytic Therapy in Loculated Pleural Collections

医学 脓胸 血胸 肺旁积液 胸腔积液 外科 胸痛 胸膜疾病 回顾性队列研究 电视胸腔镜手术 剥皮 渗出 呼吸道疾病 胸膜液 内科学 气胸
作者
Dipasri Bhattacharya,Suveer Singh,C.D.S. Katoch,M.S. Barthwal,Vikas Marwah,M. Chopra,Yogesh Garg,Rahul Tyagi,Kislay Kishore,A. Vijay,Vibha Dutta
出处
期刊:The Indian journal of chest diseases & allied sciences 卷期号:58 (1): 17-20 被引量:16
标识
DOI:10.5005/ijcdas-58-1-17
摘要

Background.Pleural fluid loculations due to complicated parapneumonic effusion (CPE), empyema, tubercular effusion and traumatic hemothorax can be managed either by video-assisted thoracoscopic surgery (VATS) or intrapleural fibrinolytic therapy (IPFT).The former is more invasive, not easily available and is also more expensive.On the other hand, IPFT is less invasive, cheaper, easily accessible and if used early, in loculated pleural collections, break loculations and early pleural peel, thereby facilitating pleural space drainage.Objective.To study the efficacy of IPFT in facilitating pleural space drainage in loculated pleural collections of diverse aetiologies.Methods.A five-year retrospective, observational study of 200 patients, with loculated pleural collections and failed tube drainage and managed with IPFT was carried out.Responders were defined as those with significant volume of fluid drained and significant radiological resolution.Results.There were 106 (53%) cases of CPE, 59 (29.5%) cases of tubercular effusion, 23 (11.5%) cases of empyema and 12 (6%) cases of hemothorax.Responders were 148 (74%) in number.The distribution of responders as per type of loculated pleural collection was as follows: CPE 88 (83%), tubercular 37 (62.7%),empyema 14 (60.8%) and traumatic hemothorax 11 (91.6%).The adverse effects were mild and included chest pain in six patients and low-grade transient fewer in three cases.Conclusions.Intrapleural fibrinolytic therapy is a safe and cost-effective option in the management of selected patients with loculated pleural effusions.[
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曾无忧发布了新的文献求助10
2秒前
喜宝完成签到 ,获得积分10
3秒前
收集快乐完成签到 ,获得积分10
6秒前
laohu完成签到,获得积分10
7秒前
北国雪未消完成签到 ,获得积分10
7秒前
orixero应助科研通管家采纳,获得10
8秒前
HEIKU应助科研通管家采纳,获得10
8秒前
大个应助科研通管家采纳,获得10
8秒前
慕青应助科研通管家采纳,获得10
8秒前
惜墨应助科研通管家采纳,获得30
8秒前
8秒前
bkagyin应助科研通管家采纳,获得10
8秒前
早发论文应助科研通管家采纳,获得10
8秒前
8秒前
斯文败类应助科研通管家采纳,获得10
8秒前
HEIKU应助科研通管家采纳,获得10
8秒前
大个应助科研通管家采纳,获得10
9秒前
guilin应助科研通管家采纳,获得10
9秒前
HEIKU应助科研通管家采纳,获得10
9秒前
田様应助科研通管家采纳,获得10
9秒前
HEIKU应助科研通管家采纳,获得10
9秒前
9秒前
高xuewen应助心随以动采纳,获得10
9秒前
11秒前
dmy完成签到,获得积分20
12秒前
星辰完成签到,获得积分10
13秒前
默认账号完成签到 ,获得积分10
14秒前
陶醉的梦柏完成签到,获得积分10
15秒前
carlitos完成签到 ,获得积分10
16秒前
16秒前
彩色芷发布了新的文献求助10
16秒前
情怀应助皇帝的床帘采纳,获得40
16秒前
17秒前
zzbbk完成签到,获得积分10
18秒前
19秒前
咕噜快逃完成签到,获得积分10
19秒前
大方元风完成签到 ,获得积分10
19秒前
fxy发布了新的文献求助10
20秒前
sissi完成签到,获得积分10
21秒前
雪儿完成签到,获得积分10
24秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3162567
求助须知:如何正确求助?哪些是违规求助? 2813460
关于积分的说明 7900578
捐赠科研通 2473036
什么是DOI,文献DOI怎么找? 1316641
科研通“疑难数据库(出版商)”最低求助积分说明 631375
版权声明 602175